Palliative surgery for cervical spine metastasis

Share this Article

Singapore Med J 2014; 55(11): 569-573; http://dx.doi.org/10.11622/smedj.2014152
Palliative surgery for cervical spine metastasis

Rao JP, Tiruchelvarayan R, Lee L
Correspondence: Dr Rajendra Tiruchelvarayan, rajspineclinic@gmail.com

ABSTRACT
INTRODUCTION The present study aimed to assess the immediate/early clinical outcomes and surgical results of 11 consecutive patients who underwent palliative cervical spine surgery for symptomatic spinal metastases.
METHODS This single-surgeon retrospective case series analysed 12 surgical procedures that were performed for symptomatic cervical spinal metastasis in 11 consecutive patients. All surgeries were carried out at Singapore General Hospital, Singapore, from 2007 to 2013. Preoperative medical oncological assessment/staging was performed on each patient – all patients presented with either axial neck pain or neurological deficits, and had no bladder or bowel symptoms. The primary outcomes analysed were postoperative neurological power and improvement in neck pain.
RESULTS Anterior (n = 5), posterior (n = 4) and combined (n = 2) surgical approaches were used for decompression and stabilisation. Comparing between pre- and postoperative pain scores (scored according to the visual analog scale), and pre- and postoperative limb power scores (scored according to the Medical Research Council scale for muscle strength), we found that all patients showed improvement in their symptoms. Postoperatively, patients had either improvement or preservation of neurological power, and all patients had a decrease in axial neck pain after surgery. Although there was one case of minor pedicle screw instrumentation malplacement, this did not result in any neurological symptoms. Median survival for the patients was 108 (range 7?1,095) days.
CONCLUSION Palliative surgery for cervical spine metastasis is safe with good neurological results, low complication rates, and improvement in neck pain. A multidisciplinary approach involving surgeons, medical oncologists and radiotherapists is needed to optimise patient care and outcome.

Keywords: cervical spine, metastasis, palliative surgery
Singapore Med J 2014; 55(11): 569-573; http://dx.doi.org/10.11622/smedj.2014152

REFERENCES

1. Bartels RH, van der Linden YM, van der Graff WT. Spinal extradural metastasis: review of current treatment options. CA Cancer J Clin 2008; 58:245?59.
http://dx.doi.org/10.3322/CA.2007.0016
 
2. Quan GM, Vital JM, Pointillart V. Outcomes of palliative surgery in metastatic disease of the cervical and cervicothoracic spine. J Neurosurg Spine 2011; 14:612?8.
PMid:21375384
 
3. Oda I, Abumi K, Ito M, et al. Palliative spinal reconstruction using cervical pedicle screws for metastatic lesions of the spine: a retrospective analysis of 32 cases. Spine (Phila Pa 1976) 2006; 31:1439?44.
 
4. Bartels RH, Feuth T, van der Maazen R, et al. Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer 2007; 110:2042?9.
http://dx.doi.org/10.1002/cncr.23002
 
5. Sciubba DM, Gokaslan ZL. Are patients satisfied after surgery for metastatic spine disease. Spine J 2010; 10:63?5.
http://dx.doi.org/10.1016/j.spinee.2009.10.004
 
6. Fehlings MG, David KS, Vialle L, et al. Decision making in the surgical treatment of cervical spine metastases. Spine (Phila Pa 1976) 2009; 34:S108?17.
 
7. Marchesi DG, Boos N, Aebi M. Surgical treatment of tumors of the cervical spine and first two thoracic vertebrae. J Spinal Disord 1993; 6:489?96.
http://dx.doi.org/10.1097/00002517-199306060-00004
 
8. Jónsson B, Jónsson H Jr, Karlström G, Sjöström L. Surgery of cervical spine metastases: a retrospective study. Eur Spine J 1994; 3:76?83.
http://dx.doi.org/10.1007/BF02221444
 
9. Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty's Stationery Office, 1981.
 
10. Kim A, Fall P, Wang D. Palliative care: optimizing quality of life. J Am Osteopath Assoc 2005; 105:S9?14.
PMid:16368908
 
11. Rao S, Badani K, Schildhauer T, Borges M. Metastatic malignancy of the cervical spine. A nonoperative history. Spine (Phila Pa 1976) 1992; 17:S407?12.
 
12. Tanner J, Gould D, Jenkins P, et al. A fresh look at preoperative body washing. J Infect Prev 2012; 13:11?5.
http://dx.doi.org/10.1177/1757177411428095

Short-term result of arthroscopic synovial excision for dorsal wrist pain in hyperextension associated with synovial hypertrophy

Share this Article

Singapore Med J 2014; 55(10): 547-549; http://dx.doi.org/10.11622/smedj.2014139
Short-term result of arthroscopic synovial excision for dorsal wrist pain in hyperextension associated with synovial hypertrophy

Jain K, Singh R
Correspondence: Dr Kowshik Jain, kowshikjain@gmail.com

ABSTRACT
INTRODUCTION Arthroscopic excision of the hypertrophic dorsal synovium is performed on patients with dorsal wrist pain in hyperextension. Although dorsal wrist impingement has been described in cadaveric studies, to our knowledge, there is no published clinical data on its treatment with arthroscopic synovial excision. Herein, we present the results of arthroscopic management of this condition in our hospital.
METHOD A total of 13 patients underwent arthroscopic excision of the hypertrophic dorsal impinging synovium. All patients presented with the cardinal symptom of dorsal-radial wrist pain in extreme extension. The diagnoses were made after excluding other causes and confirmed on wrist arthroscopy. Arthroscopy was offered after nonoperative measures failed. The mean postoperative follow-up period was 14 (range 6–31) months.
RESULTS Mean pre- and postoperative quick Disabilities of the Arm, Shoulder and Hand scores were 49 (range 34–82) and 17 (range 0–48), respectively; paired t-test revealed a significant difference between the two (p < 0.001). Mean postoperative flexion-extension arc and radial-ulnar deviation arc were 120º and 46º, respectively. Postoperatively, one patient developed complex regional pain syndrome, with tethering of the dorsal branch of the ulnar nerve, which required surgical release, while another patient required revision arthroscopic excision of the impinging tissue. Both patients had good postoperative outcomes.
CONCLUSION When treating patients with dorsal wrist pain, dorsal wrist impingement caused by synovial hypertrophy should be included in the differential diagnosis. Arthroscopic excision of the impinging synovium can achieve reliable pain relief with significant functional improvement in the short term, although further research on its long-term benefits is required.

Keywords: arthroscopic, impingement, pain, synovium, wrist
Singapore Med J 2014; 55(10): 547-549; http://dx.doi.org/10.11622/smedj.2014139

REFERENCES

1. Henry M. Arthroscopic management of dorsal wrist impingement. J Hand Surg Am 2008; 33:1201-4.
http://dx.doi.org/10.1016/j.jhsa.2008.06.020
 
2. Ruby LK, Cooney WP 3rd, An KN, Linscheid RL, Chao EY. Relative motion of selected carpal bones: a kinematic analysis of the normal wrist. J Hand Surg Am 1988; 13:1-10.
http://dx.doi.org/10.1016/0363-5023(88)90189-X
 
3. Youm Y, McMurtry RY, Flatt AE, Gillepsie TE. Kinematics of the wrist. I. An experimental study of radial-ulnar deviation and flexion-extension. J Bone Joint Surg Am 1978; 60:423-31.
PMid:670263
 
4. Wollstein R, Watson HK, Wear-Maggitti K, Schmidt S, Carlson L. Surgical technique for the treatment of radial wrist pain. Scand J Plast Reconstr Surg Hand Surg 2008; 42:149-52.
http://dx.doi.org/10.1080/02844310801987685
 
5. Nagle DJ. Evaluation of chronic wrist pain. J Am Acad Orthop Surg 2000; 8:45-55.
PMid:10666652
 
6. Weinzweig J, Watson HK. Dorsal wrist syndrome repair. In: Watson HK, Weinzweig J. The Wrist. Philadelphia: Lippincott Williams & Wilkins, 2001: 829-31.
 
7. Watson H, Ottoni L, Pitts EC, Handal AG. Rotary subluxation of the scaphoid: a spectrum of instability. J Hand Surg Br 1993; 18:62-4.
http://dx.doi.org/10.1016/0266-7681(93)90199-P
 
8. VanHeest AE, Luger NM, House JH, Vener M. Extensor retinaculum impingement in the athlete: a new diagnosis. Am J Sports Med 2007; 35:2126-30.
http://dx.doi.org/10.1177/0363546507305803
 
9. Yasuda M, Masada K, Takeuchi E. Dorsal wrist syndrome repair. Hand Surg 2004; 9:45-8.
http://dx.doi.org/10.1142/S0218810404002054
 
10. Tan SW, Ng SW, Tan SH, Teoh LC. Arthroscopic debridement of intercarpal ligament and triangular fibrocartilage complex tears. Singapore Med J 2012; 53:188-91.
PMid:22434293
 
11. Weiss AP, Sachar K, Glowacki KA. Arthroscopic debridement alone for intercarpal ligament tears. J Hand Surg Am 1997; 22:344-9.
http://dx.doi.org/10.1016/S0363-5023(97)80176-1

Incidence and outcome of bone metastatic disease at University Malaya Medical Centre

Share this Article

Singapore Med J 2014; 55(10): 539-546; http://dx.doi.org/10.11622/smedj.2014138
Incidence and outcome of bone metastatic disease at University Malaya Medical Centre

Singh VA, Haseeb A, Alkubaisi AA
Correspondence: Dr Vivek Ajit Singh, drvivek69@gmail.com

ABSTRACT
INTRODUCTION Morbidity and mortality from malignant diseases are usually the result of metastasis. The bone is the third most common site of metastasis.
METHODS This is a retrospective study of patients with metastatic bone disease who were referred to the Orthopaedic Department of University Malaya Medical Centre, Malaysia, between January 2004 and October 2009.
RESULTS A total of 151 patients (51.0% men, 49.0% women) had metastatic bone disease, with the highest incidence at the age range of 50–59 years. The commonest primary cancer was breast (23.3%), followed by lung (21.2%), prostate (9.3%), thyroid (7.3%) and renal cell carcinoma (5.3%); unknown primary cancer was 6.6%. There was long bone involvement in 52.7% of cases, axial bone in 44.5%, and both long and axial bones in 2.8%. The majority (90.1%) were symptomatic, with pain as the commonest symptom. 106 (70.2%) patients had pathological fractures. Neurological deficit was reported in 90.7% of patients, with 41.1% having extraskeletal metastases. 67.8% of the lesions were osteolytic, 24.3% were sclerotic, and 7.9%, mixed. Palliative and therapeutic interventions were undertaken for 62.0% of patients. The mean survival times were: breast 21.0; thyroid 20.7; prostate 20.3; lung 16.0; and unknown primary cancer 32.6 months.
CONCLUSION In our study, breast and lung cancers were the commonest primary cancers in metastatic bone disease. Most patients had more than one site of involvement, pain at presentation and pathological fractures. Surgery is beneficial to relieve pain and improve function and neurology. Duration of survival depends on the type of primary cancer and whether systemic metastasis is present.

Keywords: bone, metastasis, outcome, survival
Singapore Med J 2014; 55(10): 539-546; http://dx.doi.org/10.11622/smedj.2014138

REFERENCES

1. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27:165-76.
http://dx.doi.org/10.1053/ctrv.2000.0210
 
2. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991; 9:509-24.
PMid:1705581
 
3. Schaberg J, Gainor BJ. A profile of metastatic carcinoma of the spine. Spine (Phila Pa 1976) 1985; 10:19-20.
http://dx.doi.org/10.1097/00007632-198501000-00003
 
4. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosingimpending pathologic fractures. Clin Orthop Relat Res 1989; 256-64.
PMid:2684463
 
5. American Cancer Society. Cancer-related pain: A guide for patients and caregivers. http://www.cancer.org/acs/groups/content/documents/document/acspc-030531.... Accessed October 13, 2014.
 
6. Frankel HL, Hancock DO, Hyslop G, et al. The value of posturalreduction in the initial management of close injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969; 7:179-92.
http://dx.doi.org/10.1038/sc.1969.30
 
7. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12:6243s-9s.
http://dx.doi.org/10.1158/1078-0432.CCR-06-0931
 
8. Harrington KD. Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect 1986; 35:357?81.
PMid:3819423
 
9. Sundaresan N, DiGiacinto GV, Krol G, Hughes JE. Spondylectomy for malignant tumors of the spine. J Clin Oncol 1989; 7:1485-91.
PMid:2778479
 
10. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997; 69:1-18.
http://dx.doi.org/10.1016/S0304-3959(96)03267-8
 
11. Selvaggi G, Scagliotti GV. Management of bone metastases in cancer: a review.Crit Rev Oncol Hematol 2005; 56:365-78.
http://dx.doi.org/10.1016/j.critrevonc.2005.03.011
 
12. Chow E, Hoskin P, van der Linden Y, Bottomley A, Velikova G. Quality of life and symptom end points in palliative bone metastases trials. Clin Oncol (R Coll Radiol) 2006; 18:67-9.
http://dx.doi.org/10.1016/j.clon.2005.06.016
 
13. Mercadante S, Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 1998; 24:425-32.
http://dx.doi.org/10.1016/S0305-7372(98)90005-6
 
14. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353:1695-700.
http://dx.doi.org/10.1016/S0140-6736(99)01310-0
 
15. Banning A, Sjøgren P, Henriksen H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain 1991; 45:45-8.
http://dx.doi.org/10.1016/0304-3959(91)90163-R
 
16. Coleman RE. How can we improve the treatment of bone metastases further? Curr Opin Oncol 1998; 10 Suppl 1:S7-13.
PMid:9801853
 
17. Coleman RE, Houston S, Purohit OP, et al. A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. Eur J Cancer 1998; 34:820-4.
http://dx.doi.org/10.1016/S0959-8049(97)10155-1
 
18. Tillman RM. The role of the orthopaedic surgeon in metastatic disease of the appendicular skeleton.Working Party on Metastatic Bone Disease in Breast Cancer in the UK. J Bone Joint Surg Br 1999; 81:1-2.
http://dx.doi.org/10.1302/0301-620X.81B1.9514
 
19. Kunisada T, Choong PF. Major reconstruction for periacetabular metastasis: early complications and outcome following surgical treatment in 40 hips. Acta Orthop Scand 2000; 71:585-90.
http://dx.doi.org/10.1080/000164700317362217
 
20. Posner JB, Howieson J, Cvitkovic E. "Disappearing" spinal cord compression: oncolytic effect of glucocorticoids (and other chemotherapeutic agents) on epidural metastases. Ann Neurol 1977; 2:409-13.
http://dx.doi.org/10.1002/ana.410020511
 
21. Gabriel K, Schiff D. Metastatic spinal cord compression by solid tumors. Semin Neurol 2004; 24:375-83.
http://dx.doi.org/10.1055/s-2004-861532
 
22. Tatsui H, Onomura T, MorishitaS, Oketa M, Inoue T. Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation. Spine (Phila Pa 1976) 1996; 21:2143?8.
 
23. Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer 2007; 57:229-32.
http://dx.doi.org/10.1016/j.lungcan.2007.03.013
 
24. Paterson AH, Powles TJ, Kanis JA, et al. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11:59-65.
PMid:8418243
 
25. Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ. Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 1992; 21:173-80.
http://dx.doi.org/10.1007/BF01975000
 
26. Saad F, Karakiewicz P, Perrotte P. The role of bisphosphonates in hormone-refractory prostate cancer. World J Urol 2005; 23:14-8.
http://dx.doi.org/10.1007/s00345-004-0472-2
 
27. Pittas AG, Adler M, Fazzari M, et al. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 2000; 10:261-8.
http://dx.doi.org/10.1089/thy.2000.10.261
 
28. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005; 54:243-50.
http://dx.doi.org/10.1016/j.critrevonc.2004.10.002
 
29. Krementz ET, Cerise EJ, Foster DS, Morgan LR Jr. Metastases of undetermined source. Curr Probl Cancer 1979; 4:4-37.
http://dx.doi.org/10.1016/S0147-0272(79)80019-7
 
30. Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non–small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009; 27:4247-53.
http://dx.doi.org/10.1200/JCO.2009.22.6993
 
31. Toyoda Y, Shinohara N, Harabayashi T, et al. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 2007; 52:163-8.
http://dx.doi.org/10.1016/j.eururo.2006.10.060
 
32. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001; 26:298-306.
http://dx.doi.org/10.1097/00007632-200102010-00016
 
33. Kuru B, Camlibel M, Dinc S, et al. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singapore Med J 2008; 49:904-11.
PMid:19037557
 
34. Swenerton KD, Legha SS, Smith T, et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979; 39:1552-62.
PMid:427797
 
35. Brown JE, Cook RJ, Major P, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 2005; 97:59-69.
http://dx.doi.org/10.1093/jnci/dji002

Risk factors of surgical site infections in hip hemiarthroplasty: a single-institution experience over nine years

Share this Article

Singapore Med J 2014; 55(10): 535-538; http://dx.doi.org/10.11622/smedj.2014137
Risk factors of surgical site infections in hip hemiarthroplasty: a single-institution experience over nine years

Lau A, Neo GH, Lee HC
Correspondence: Dr Adrian Lau Cheng Kiang, adrianlck@yahoo.com

ABSTRACT
INTRODUCTION This study aims to describe the factors associated with surgical site infection (SSI) in elderly patients who underwent hip hemiarthroplasty following a hip fracture, in a single institution over a nine-year period.
METHODS All patients who underwent hip hemiarthroplasty between 1 January 2004 and 31 December 2012 in our hospital were included in the present study. The detection of SSI was carried out by a trained, independent infection control nurse using the United States Centers for Disease Control and Prevention criteria. Demographic and clinical data were collected retrospectively. Demographics and clinical factors were analysed for potential associations with SSI.
RESULTS Among the 1,320 patients who met the study inclusion criteria, a total 57 SSIs were documented, giving an infection rate of 4.3%. Patients who waited for more than one week for surgery had a statistically significantly higher risk of SSI (odds ratio 3.030, 95% confidence interval 1.075–8.545, p = 0.036). The presence of SSI was also significantly associated with increased length of hospital stay (p < 0.001). The two main microorganisms detected were methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, which accounted for 50.9% and 26.3% of the SSIs, respectively.
CONCLUSION We concluded that the number of days from admission to surgery is a main risk factor for the development of SSI. Steps should, therefore, be taken to prevent unnecessary delay of surgery in elderly patients requiring hip hemiarthroplasty.

Keywords: hemiarthroplasty, neck of femur, surgical site infections
Singapore Med J 2014; 55(10): 535-538; http://dx.doi.org/10.11622/smedj.2014137

REFERENCES

1. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23:183-9.
http://dx.doi.org/10.1086/502033
 
2. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122:160-6.
PMid:17357358 PMCid:PMC1820440
 
3. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-8.
http://dx.doi.org/10.2307/30148464
 
4. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19:19-35.
http://dx.doi.org/10.1016/0196-6553(91)90157-8
 
5. Ridgeway S, Wilson J, Charlet A, et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005; 87:844-50.
http://dx.doi.org/10.1302/0301-620X.87B6.15121
 
6. Lee J, Singletary R, Schmader K, et al. Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am 2006; 88:1705-12.
http://dx.doi.org/10.2106/JBJS.E.01156
 
7. Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am 2005; 87:483-9.
http://dx.doi.org/10.2106/JBJS.D.01796
 
8. Zuckerman JD, Skovron ML, Koval KJ, Aharonoff G, Frankel VH. Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Joint Surg Am 1995; 77:1551-6.
PMid:7593064
 
9. Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 2008; 55:146-54.
http://dx.doi.org/10.1007/BF03016088
 
10. Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res 2013; 471:3112-9.
http://dx.doi.org/10.1007/s11999-013-2923-9
 
11. Smith TO, Sexton D, Mann C, Donell S. Sutures versus staples for skin closure in orthopaedic surgery: meta-analysis. BMJ 2010; 340:c1199.
http://dx.doi.org/10.1136/bmj.c1199
 
12. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003; 37:1453-60.
http://dx.doi.org/10.1086/379321
 
13. Blumberg HM. Community acquired versus healthcare-associated methicillin resistant (MRSA) infections: is the distinction blurring? Clinical Updates in Infectious Diseases 2009; 12:1-6.

Early experiences with robot-assisted total knee arthroplasty using the DigiMatchTM ROBODOC(R) surgical system

Share this Article

Singapore Med J 2014; 55(10): 529-534; http://dx.doi.org/10.11622/smedj.2014136
Early experiences with robot-assisted total knee arthroplasty using the DigiMatchTM ROBODOC(R) surgical system

Liow MH, Chin PL, Tay KJ, Chia SL, Lo NN, Yeo SJ
Correspondence: Dr Liow Ming Han Lincoln, lincoln.liow.m.h@sgh.com.sg

ABSTRACT
INTRODUCTION The use of robotics in total knee arthroplasty (TKA) has been shown to minimise human error, as well as improve the accuracy and precision of component implantation and mechanical axis alignment. The present study aimed to demonstrate that robot-assisted TKA using ROBODOC® is safe and capable of producing a consistent and accurate postoperative mechanical axis.
METHODS We prospectively recruited 27 consecutive patients who underwent robot-assisted TKA between May and December 2012. Two patients were excluded from the study due to intraoperative technical problems with the robot. Long-leg radiography and computed tomography were performed prior to surgery, and used for mechanical axis measurements and component sizing. DigiMatch™ ROBODOC® Surgical System software version 4.3.6 (Curexo Technology Corp, Fremont, CA, USA) was used in all cases to perform bone cuts in accordance with the preoperative plan.
RESULTS The postoperative coronal mechanical alignment was within 3 degrees, with a mean alignment of –0.4 ± 1.7 degrees, confirming the accuracy of the preoperative surgical plan and bone cuts. The mean operating time was 96 ± 15 min, and preoperative planning yielded 100% implant sizing accuracy.
CONCLUSION Robotics has the potential to enable surgeons to consistently attain ideal postoperative alignment. The use of bone movement monitors and an integrated navigation system enhances the safety profi le of ROBODOC® by minimising errors. However, the role of the surgeon in TKA is still vital, as the surgeon is ultimately in charge of planning the surgery, its execution and ensuring soft tissue balance during TKA.

Keywords: coronal mechanical axis alignment, ROBODOC®, robot-assisted, robotic surgery, total knee arthroplasty
Singapore Med J 2014; 55(10): 529-534; http://dx.doi.org/10.11622/smedj.2014136

REFERENCES

1. Paul HA, Bargar WL, Mittlestadt B, et al. Development of a surgical robot for cementless total hip arthroplasty. Clin Orthop Relat Res 1992; 57-66.
PMid:1446455
 
2. Park SE, Lee CT. Comparison of robotic-assisted and conventional manual implantation of a primary total knee arthroplasty. J Arthroplasty 2007; 22:1054-9.
http://dx.doi.org/10.1016/j.arth.2007.05.036
 
3. Tew M, Waugh W. Tibiofemoral alignment and the results of knee replacement. J Bone Joint Surg Br 1985; 67:551-6.
PMid:4030849
 
4. Bellemans J, Vandenneucker H, Vanlauwe J. Robot-assisted total knee arthroplasty. Clin Orthop Relat Res 2007; 464:111-6.
PMid:17563698
 
5. Song EK, Seon JK, Yim JH, Netravali NA, Bargar WL. Robotic-assisted TKA reduces postoperative alignment outliers and improves gap balance compared to conventional TKA. Clin Orthop Relat Res 2013; 471:118-26.
http://dx.doi.org/10.1007/s11999-012-2407-3
 
6. Borner M, Wiesel U, Ditzen W. Clinical experiences with Robodoc and the Duracon Total Knee. In: Stiehl JB, Konermann WH, Haaker RG, eds. Navigation and Robotics in Total Joint and Spine Surgery. Berlin: Springer, 2004: 362-6.
http://dx.doi.org/10.1007/978-3-642-59290-4_51
 
7. Mai S, Lorke C, Siebert W. Clinical results with the robot-assisted Caspar System and the Search-Evolution Prosthesis. In: Stiehl JB, Konermann WH, Haaker RG, eds. Navigation and Robotics in Total Joint and Spine Surgery. Berlin: Springer, 2004: 355-61.
http://dx.doi.org/10.1007/978-3-642-59290-4_50
 
8. Decking J, Theis C, Achenbach T, et al. Robotic total knee arthroplasty: the accuracy of CT-based component placement. Acta Orthop Scand 2004; 75:573-9.
http://dx.doi.org/10.1080/00016470410001448
 
9. Kharwadkar N, Kent RE, Sharara KH, Naique S. 5 degrees to 6 degrees of distal femoral cut for uncomplicated primary total knee arthroplasty: is it safe? Knee 2006; 13:57-60.
http://dx.doi.org/10.1016/j.knee.2005.07.001
 
10. Bardakos N, Cil A, Thompson B, Stocks G. Mechanical axis cannot be restored in total knee arthroplasty with a fixed valgus resection angle: a radiographic study. J Arthroplasty 2007; 22:85-9.
http://dx.doi.org/10.1016/j.arth.2007.04.018
 
11. Churchill DL, Incavo SJ, Johnson CC, Beynnon BD. The transepicondylar axis approximates the optimal flexion axis of the knee. Clin Orthop Relat Res 1998; 111-8.
http://dx.doi.org/10.1097/00003086-199811000-00016
 
12. Kawamura H, Bourne RB. Factors affecting range of flexion after total knee arthroplasty. J Orthop Sci 2001; 6:248-52.
http://dx.doi.org/10.1007/s007760100043
 
13. Fehring TK. Rotational malalignment of the femoral component in total knee arthroplasty. Clin Orthop Relat Res 2000; 72-9.
http://dx.doi.org/10.1097/00003086-200011000-00010
 
14. Miller MC, Berger RA, Petrella AJ, Karmas A, Rubash HE. Optimizing femoral component rotation in total knee arthroplasty. Clin Orthop Relat Res 2001; 38-45.
http://dx.doi.org/10.1097/00003086-200111000-00005
 
15. Nagamine R, Miura H, Bravo CV, et al. Anatomic variations should be considered in total knee arthroplasty. J Orthop Sci 2000; 5:232-7.
http://dx.doi.org/10.1007/s007760050157
 
16. Bellemans J. Osseointegration of porous coated knee arthroplasty. The influence of component coating type in sheep. Acta Orthop Scand Suppl 1999; 288:1-35.
PMid:10949554
 
17. Denis K, Van Ham G, Vander Sloten J, et al. Infl uence of bone milling parameters on the temperature rise, milling forces and surface flatness in view of robot-assisted total knee arthroplasty. Int Congr Ser 2001; 1230:300-6.
http://dx.doi.org/10.1016/S0531-5131(01)00067-X
 
18. Eriksson R, Albrektsson T. The effect of heat on bone regeneration: an experimental study in the rabbit using the bone growth chamber. J Oral Maxillofac Surg 1984; 42:705-11.
http://dx.doi.org/10.1016/0278-2391(84)90417-8
 
19. Choong PF, Dowsey MM, Stoney JD. Does accurate anatomical alignment result in better function and quality of life? Comparing conventional and computer-assisted total knee arthroplasty. J Arthroplasty 2009; 24:560-9.
http://dx.doi.org/10.1016/j.arth.2008.02.018
 
20. Jenny JY, Clemens U, Kohler S, et al. Consistency of implantation of a total knee arthroplasty with a non-image-based navigation system: a case control study of 235 cases compared with 235 conventionally implanted prostheses. J Arthroplasty 2005; 20:832-9.
http://dx.doi.org/10.1016/j.arth.2005.02.002
 
21. Jeffery RS, Morris RW, Denham RA. Coronal alignment after total knee replacement. J Bone Joint Surg Br 1991; 73:709-14.
PMid:1894655
 
22. Lotke PA, Ecker ML. Infl uence of positioning of the prosthesis in total knee replacement. J Bone Joint Surg Am 1977; 59:77-9.
PMid:833180
 
23. Song EK, Seon JK, Park SJ, et al. Simultaneous bilateral total knee arthroplasty with robotic and conventional techniques: a prospective, randomized study. Knee Surg Sports Traumatol Arthrosc 2011; 19:1069-76.
http://dx.doi.org/10.1007/s00167-011-1400-9
 
24. Siebert W, Mai S, Kober R, Heeckt PF. Technique and first clinical results of ROBODOC-assisted total knee replacement. Knee 2002; 9:173-80.
http://dx.doi.org/10.1016/S0968-0160(02)00015-7
 
25. Chauhan SK, Scott RG, Breidahl W, Beaver RJ. Computer-assisted knee arthroplasty versus a conventional jig-based technique. A randomized, prospective trial. J Bone Joint Surg Br 2004; 86:372-7.
http://dx.doi.org/10.1302/0301-620X.86B3.14643
 
26. Bäthis H, Perlick L, Tingart M, et al. Intraoperative cutting errors in total knee arthroplasty. Arch Orthop Trauma Surg 2005; 125:16-20.
http://dx.doi.org/10.1007/s00402-004-0759-1
 
27. Chin PL, Yang KY, Yeo SJ, Lo NN. Randomized control trial comparing radiographic total knee arthroplasty implant placement using computer navigation versus conventional technique. J Arthroplasty 2005; 20:618-26.
http://dx.doi.org/10.1016/j.arth.2005.04.004
 
28. Confalonieri N, Manzotti A, Pullen C, Ragone V. Computer-assisted technique versus intramedullary and extramedullary alignment systems in total knee replacement: a radiological comparison. Acta Orthop Belg 2005; 71:703-9.
PMid:16459861
 
29. Sparmann M, Wolke B, Czupalla H, Banzer D, Zink A. Positioning of total knee arthroplasty with and without navigation support. A prospective, randomised study. J Bone Joint Surg Br 2003; 85:830-5.
PMid:12931800
 
30. Oberst M, Berstch C, Würstlin S, Holz U. [CT analysis of leg alignment after conventional vs. navigated knee prosthesis implantation. Initial results of a controlled, prospective, and randomized study]. Unfallchirurg 2003; 106:941-8. German.
PMid:14634738
 
31. Saragaglia D, Picard F, Chaussard C, et al. [Computer-assisted knee arthroplasty: comparison with a conventional procedure. Results of 50 cases in a prospective randomized study]. Rev Chir Orthop Reparatrice Appar Mot 2001; 87:18-28. French.
 
32. Bonutti P, Dethmers D, Stiehl JB. Case report: femoral shaft fracture resulting from femoral tracker placement in navigated TKA. Clin Orthop Relat Res 2008; 466:1499-502.
http://dx.doi.org/10.1007/s11999-008-0150-6
 
33. Li CH, Chen TH, Su YP, et al. Periprosthetic femoral supracondylar fracture after total knee arthroplasty with navigation system. J Arthroplasty 2008; 23:304-7.
http://dx.doi.org/10.1016/j.arth.2006.12.049
 
34. Chun YS, Kim KI, Cho YJ, et al. Causes and patterns of aborting a robot-assisted arthroplasty. J Arthroplasty 2011; 26:621-5.
http://dx.doi.org/10.1016/j.arth.2010.05.017
 
35. Peersman G, Laskin R, Davis J, Peterson MG, Richart T. Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2006; 2:70-2.
http://dx.doi.org/10.1007/s11420-005-0130-2
 
36. Bargar WL. Robots in orthopaedic surgery: past, present, and future. Clin Orthop Relat Res 2007; 463:31-6.
PMid:17960673

Reducing allograft contamination and disease transmission: intraosseous temperatures of femoral head allografts during autoclaving

Share this Article

Singapore Med J 2014; 55(10): 526-528; http://dx.doi.org/10.11622/smedj.2014135
Reducing allograft contamination and disease transmission: intraosseous temperatures of femoral head allografts during autoclaving

Ang CY, Yew A, Tay D, Chia SL, Yeo SJ, Lo NN, Chin PL
Correspondence: Dr Ang Chay-You, angchayyou@msn.com

ABSTRACT
INTRODUCTION The Singapore General Hospital Bone Bank, which exclusively stores femoral head allografts, relies on flash sterilisation to prevent allograft-related disease transmission and wound infection. However, intraosseous temperatures during autoclaving may be lower than required to eliminate human immunodeficiency virus, and hepatitis B and C viruses. The aim of this study is to determine the intraosseous temperatures of femoral head allografts during autoclaving and to assess the adequacy of autoclaving in preventing disease transmission.
METHODS Six femoral heads were acquired from patients who underwent hip arthroplasty. The specimens were divided into two groups. The first group underwent flash sterilisation with a sterilisation time of 4 min, while a longer sterilisation time of 22 min was used for the second group.
RESULTS The highest core temperature in the first group was 130°C, while the core temperatures in the second group plateaued at 133°C for all allografts. In the first group, only smaller allografts maintained temperatures sufficient for the inactivation of the clinically relevant viral pathogens. In contrast, all allografts in the second group were terminally sterilised.
CONCLUSION There is an inverse correlation between the size of allografts and intraosseous temperatures achieved during autoclaving. Therefore, we recommend dividing large allografts into smaller pieces, in order to achieve intraosseous temperatures adequate for the elimination of transmissible pathogens during flash sterilisation. Allografts should not be terminally sterilised, as the resulting allografts will become unusable. Despite modern processing techniques, stringent donor selection remains vital in the effort to prevent allograft-related infections. Autoclaving is an economical and efficacious method of preventing allograft-related disease transmission.

Keywords: allografts, autoclaving, bone bank, disease transmission, femoral heads
Singapore Med J 2014; 55(10): 526-528; http://dx.doi.org/10.11622/smedj.2014135

REFERENCES

1. Khan SN, Cammisa FP Jr, Sandhu HS, et al. The biology of bone grafting. J Am Acad Orthop Surg 2005; 13:77-86.
PMid:15712985
 
2. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3:192-5.
http://dx.doi.org/10.1097/00005131-198909000-00002
 
3. Zwitser EW, Jiya TU, George Licher H, van Royen BJ. Design and management of an orthopaedic bone bank in The Netherlands. Cell Tissue Bank 2012; 13:63-9.
http://dx.doi.org/10.1007/s10561-010-9230-4
 
4. Galia CR, Moreira LF. The Biology of Bone Grafts. In: Fokter SK, ed. Recent Advances in Arthroplasty. InTech, 2012.
 
5. Ang CY, Loh DS, Chaw HW, Chin PL. Simple novel bone bank storage: the Singapore General Hospital experience. Biopreserv Biobank 2012; 10:526-8.
http://dx.doi.org/10.1089/bio.2012.0048
 
6. Böhm P, Stihler J. Intraosseous temperature during autoclaving. J Bone Joint Surg Br 1995; 77:649-53.
PMid:7615615
 
7. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. USA: Centers for Disease Control and Prevention, 2008.
PMCid:PMC2600382
 
8. Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326:726-32.
http://dx.doi.org/10.1056/NEJM199203123261102
 
9. Centers for Disease Control and Prevention (CDC). Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003; 52:273-4, 276.
PMid:12729075
 
10. Kobayashi H, Tsuzuki M, Koshimizu K, et al. Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 1984; 20:214-6.
PMid:6436295 PMCid:PMC271289
 
11. Charm SE, Landau S, Williams B, et al. High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang 1992; 62:12-20.
http://dx.doi.org/10.1111/j.1423-0410.1992.tb01160.x
 
12. Song H, Li J, Shi S, et al. Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J 2010; 7:40.
http://dx.doi.org/10.1186/1743-422X-7-40

Comparative assessment of students' performance and perceptions on objective structured practical models in undergraduate pathology teaching

Share this Article

Singapore Med J 2014; 55(9): 502-505; http://dx.doi.org/10.11622/smedj.2014121
Comparative assessment of students' performance and perceptions on objective structured practical models in undergraduate pathology teaching

Htwe TT, Sabaridah I, Low GK
Correspondence: Dr Than Than Htwe, lavenderhtwe@yahoo.com

ABSTRACT
INTRODUCTION Assessment is an important factor that drives student learning, as students tend to mainly focus on the material to be assessed. The current practice in teaching pathology extensively applies objective-structured practical examination for the assessment of students. As students will have to deal with real patients during clinical years, it is preferred that students learn and practise via potted specimens and slides instead of picture plates. This study aimed to assess the preferred assesment method of pathology practical exercises.
METHODS This was a cross-sectional survey carried out in two consecutive batches of Phase 2 medical students. Student competency was assessed using both the traditional (TD) (i.e. use of potted specimens and slides) and picture plate (PP) methods. To compare the two assessment methods, we compared the mean scores obtained by the students and examined student perception of the two methods.
RESULTS The mean scores obtained via the PP method were significantly higher than those obtained via the TD method for almost all the components tested.
CONCLUSION We found that students performed significantly better (p < 0.05) when assessed using the PP method instead of the TD method. PP preparations might provide better visuals, thus aiding understanding, than the TD method. The findings of this study are valuable in identifying and improving our current teaching and assessment methods of medical students, in line with advancements in information technology.

Keywords: OSPE, pathology, undergraduate medical students
Singapore Med J 2014; 55(9): 502-505; http://dx.doi.org/10.11622/smedj.2014121

REFERENCES

1. Ben-David FM. Association of Medical Education in Europe guide no.14: outcome-based education: part 3- assessment in outcome-based education. Med Teach 1999; 21:23-25.
http://dx.doi.org/10.1080/01421599979987
 
2. Amin TT, Kaliyan F, Al-Muhaidib NS. Medical students' assessment preferences at King Faisal University, Saudi Arabia. Adv Med Educ Pract 2011; 2:95-103.
http://dx.doi.org/10.2147/AMEP.S12950
 
3. Epstein RM. Assessment in medical education. N Engl J Med. 2007; 356:387-96.
http://dx.doi.org/10.1056/NEJMra054784
 
4. Domizio P. The changing role of Pathology in the Undergraduate Curriculum [online]. Available at: www.pathsoc.org/files/history/c12.pdf?phpMyAdmin=80eee55fe233044148a3957.... Accessed February 9, 2012.
 
5. Dissanayake AS, Ali BA, Nayar U. The influence of the introduction of objective structures practical examinations in physiology on student performance at King Faisal University Medical School. Med Teach 1990; 12:297-304
http://dx.doi.org/10.3109/01421599009006634
 
6. Rahman N, Ferdousi S, Hoq N, Amin R, Kabir J. Evaluation of objective structured practical examination and traditional practical examination. Mymensingh Med J 2007; 16:7-11.
http://dx.doi.org/10.3329/mmj.v16i1.239
 
7. Anonymous 2003. Tomorrow's Doctor: recommendations on undergraduate medical education. General Medical Council [online]. Available at: www.gmc-uk.org/med-ed/tomdoc.pdf. Accessed December 3, 2003.
 
8. Mattick K, Marshall R and Bligh J. Tissue pathology in undergraduate medical education: atrophy or evolution? J Pathol 2004; 203:871-6.
http://dx.doi.org/10.1002/path.1601
 
9. Marshall R, Cartwright N, Mattick K. Teaching and learning pathology: a critical review of the English literature. Med Edu 2004; 38: 302-13.
http://dx.doi.org/10.1111/j.1365-2923.2004.01775.x
 
10. Htwe TT, Sabaridah I, Rajyaguru KM and Mazidah AM. Pathology crossword competition: an active and easy way of learning pathology in undergraduate medical education. Singapore Med J 2012; 53:121-3.
PMid:22337187

Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population

Share this Article

Singapore Med J 2014; 55(9): 493-501; http://dx.doi.org/10.11622/smedj.2014120
Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population

Songpatanasilp T, Mumtaz M, Chhabra H, Yu M, Sorsaburu S
Correspondence: Dr Thawee Songpatanasilp, thaweesps@yahoo.com

ABSTRACT
INTRODUCTION We evaluated reduced back pain in a multiethnic population treated with teriparatide and/or antiresorptives in real-life clinical settings over 12 months.
METHODS This prospective observational study comprised 562 men and postmenopausal women (mean age 68.8 years) receiving either teriparatide (n = 230), antiresorptives (raloxifene or bisphosphonates; n = 322), or both (n = 10) for severe osteoporosis. The primary endpoint was the relative risk of new/worsening back pain at six months.
RESULTS At baseline, a higher proportion of teriparatide-treated than antiresorptive-treated patients had severe back pain (30.9% vs. 17.7%), extreme pain/discomfort (25.3% vs. 16.8%), extreme anxiety/depression (16.6% vs. 7.8%) and were confined to bed (10.0% vs. 5.3%). Teriparatide-treated patients had higher visual analog scale (VAS) scores for pain (5.8 ± 2.42 vs. 5.1 ± 2.58) and lower mean European Quality of Life-5 Dimensions (EQ-5D) scores (37.7 ± 29.15 vs. 45.5 ± 31.42) than antiresorptive-treated patients. The incidence of new/worsening back pain at six months for patients on teriparatide and antiresorptives was 9.8% and 10.3% (relative risk 0.99, 95% confidence interval 0.80–1.23), respectively. The incidence of severe back pain at 12 months was 1.3% and 1.6% in the teriparatide and antiresorptive treatment groups, respectively. Teriparatide-treated patients had lower mean VAS (2.71 ± 2.21 vs. 3.30 ± 2.37) and EQ?5D (46.1 ± 33.18 vs. 55.4 ± 32.65) scores at 12 months. More teriparatide-treated patients felt better (82.7% vs. 71.0%) and were very satisfied with treatment (49.4% vs. 36.8%) compared to antiresorptive-treated patients.
CONCLUSION Patients treated with either teriparatide or antiresorptives had similar risk of new/worsening back pain at six months.

Keywords: antiresorptives, back pain, EQ-5D, osteoporosis, teriparatide
Singapore Med J 2014; 55(9): 493-501; http://dx.doi.org/10.11622/smedj.2014120

REFERENCES

1. Silverman SL, Piziak VK, Chen P, Misurski DA, Wagman RB. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 2005; 32:2405-9.
PMid:16331772
 
2. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348:1535-41.
http://dx.doi.org/10.1016/S0140-6736(96)07088-2
 
3. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999; 282:1344-52.
http://dx.doi.org/10.1001/jama.282.14.1344
 
4. Guyatt GH, Cranney A, Griffith L, et al. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am 2002; 31:659?79, xii.
http://dx.doi.org/10.1016/S0889-8529(02)00024-5
 
5. Delmas PD, Recker RR, Chesnut CH 3rd, et al. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporosos Int 2004; 15:792-8.
http://dx.doi.org/10.1007/s00198-004-1602-9
 
6. Russell RG, Rogers MJ, Frith JC, et al. The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 1999; 14 suppl 2:53-65.
http://dx.doi.org/10.1002/jbmr.5650140212
 
7. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344:1434-41.
http://dx.doi.org/10.1056/NEJM200105103441904
 
8. Jiang Y, Zhao JJ, Mitlak BH, et al. Recombinant human parathyroid hormone (1-34)[teriparatide]improves both cortical and cancellous bone structure. J Bone Miner Res 2003; 18:1932-41.
http://dx.doi.org/10.1359/jbmr.2003.18.11.1932
 
9. Kaufman JM, Orwoll E, Goemaere S, et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 2005; 16:510-16.
http://dx.doi.org/10.1007/s00198-004-1713-3
 
10. Liberman UA, Weiss SR, Bröll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995; 333:1437-43.
http://dx.doi.org/10.1056/NEJM199511303332201
 
11. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998; 280:2077-82.
http://dx.doi.org/10.1001/jama.280.24.2077
 
12. Chesnut CH 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000; 109:267-76.
http://dx.doi.org/10.1016/S0002-9343(00)00490-3
 
13. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282:637-45.
http://dx.doi.org/10.1001/jama.282.7.637
 
14. Jakob F, Oertel H, Langdahl B, et al. Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study. Eur J Endocrinol 2012; 166:87-97.
http://dx.doi.org/10.1530/EJE-11-0740
 
15. Fahrleitner-Pammer A, Langdahl BL, Marin F. et al. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporos Int 2011; 22:2709-19.
http://dx.doi.org/10.1007/s00198-010-1498-5
 
16. Lyritis G, Marin F, Barker C, et al. Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Curr Med Res Opin 2010; 26:1799-807.
http://dx.doi.org/10.1185/03007995.2010.488516
 
17. Nevitt MC, Chen P, Dore RK, et al. Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 2006; 17:273-80.
http://dx.doi.org/10.1007/s00198-005-2013-2
 
18. Nevitt MC, Chen P, Kiel DP, et al. Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis. Osteoporos Int 2006; 17:1630-7.
http://dx.doi.org/10.1007/s00198-006-0177-z
 
19. Hadji P, Zanchetta JR, Russo L, et al. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int 2012; 23:2141-50.
http://dx.doi.org/10.1007/s00198-011-1856-y
 
20. Miyauchi A, Matsumoto T, Shigeta H, et al. Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study. J Bone Miner Metab 2008; 26:624-34.
http://dx.doi.org/10.1007/s00774-008-0871-3
 
21. Choi WH, Kim GS, Lim SK, et al. Comparison of teriparatide and calcitonin treatment in postmenopausal Korean women with osteoporosis. J Korean Soc Osteoporos 2005; 3:110-120.
 
22. Dai KR, Chen DC, Zhang ZL, et al. Comparison of the effects of subcutaneous teriparatide and intranasal calcitonin in treating established osteoporosis in postmenopausal Chinese women. Chin J Osteoporos Bone Miner Res 2011; 4:23-31.
 
23. Hwang JS, Tu ST, Yang TS, et al. Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis. Osteoporos Int 2006; 17:373-8.
http://dx.doi.org/10.1007/s00198-005-2002-5
 
24. Kung AW, Pasion EG, Sofiyan M, et al. A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study. Curr Med Res Opin 2006; 22:929-37.
http://dx.doi.org/10.1185/030079906X104768
 
25. Miyauchi A, Matsumoto T, Sugimoto T, et al. Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 2010; 47:493-502.
http://dx.doi.org/10.1016/j.bone.2010.05.022
 
26. Reginster JY, Collette J, Neuprez A, et al. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 2008; 42:832-6.
http://dx.doi.org/10.1016/j.bone.2008.01.021
 
27. Chinese Society of Osteoporosis and Bone Mineral Diseases branch. Diagnosis and treatment of primary osteoporosis guide (2011). Chin J Osteoporos Bone Miner Res 2011; 4:2-17.
 
28. Mithal A, Dhingra V, Lau E. The Asian Audit: Epidemiology, costs and burden of osteoporosis in Asia 2009. Switzerland: International Osteoporosis Foundation, 2009.
PMCid:PMC2836750
 
29. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33:337?43.
http://dx.doi.org/10.3109/07853890109002087
 
30. Body JJ, Gaich GA, Scheele WH, et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)]with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002; 87:4528-35.
http://dx.doi.org/10.1210/jc.2002-020334
 
31. Kallmes DF, Comstock BA, Heagerty PJ, et al, A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009; 361:569-79.
http://dx.doi.org/10.1056/NEJMoa0900563
 
32. McClung MR, San Martin J, Miller PD, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 2005; 165:1762-8.
http://dx.doi.org/10.1001/archinte.165.15.1762
 
33. Saag KG, Shane E, Boonen S, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007; 357:2028-39.
http://dx.doi.org/10.1056/NEJMoa071408
 
34. Saag KG, Zanchetta JR, Devogelaer JP, et al. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum 2009; 60:3346-55.
http://dx.doi.org/10.1002/art.24879

Overlap syndrome between chronic obstructive pulmonary disease and obstructive sleep apnoea in a Southeast Asian teaching hospital

Share this Article

Singapore Med J 2014; 55(9): 488-492; http://dx.doi.org/10.11622/smedj.2014117
Overlap syndrome between chronic obstructive pulmonary disease and obstructive sleep apnoea in a Southeast Asian teaching hospital

Venkateswaran S, Tee A
Correspondence: Dr Sridhar Venkateswaran, sridhar_venkateswaran@cgh.com.sg

ABSTRACT
INTRODUCTION Overlap syndrome between obstructive sleep apnoea (OSA) and chronic obstructive pulmonary disease (COPD) is important but under-recognised. We aimed to determine the prevalence of overlap syndrome and the predictors of OSA in patients with COPD.
METHODS Patients aged ≥ 40 years were recruited from a dedicated COPD clinic and underwent overnight polysomnography. A diagnosis of OSA was made when apnoea-hypopnoea index (AHI) was ≥ 5.
RESULTS In all, 22 patients (aged 71 ± 9 years), predominantly men, were recruited. Mean values recorded were: predicted forced expiratory volume in the first second percentage 55 ± 15; body mass index 23.7 ± 6.5 kg/m2; Epworth Sleepiness Scale score 5.6 ± 5.8; and AHI 15.8 ± 18.6. Among the 14 patients with OSA (prevalence of overlap syndrome at 63.6%), the mean number of hospital visits for COPD exacerbations in the preceding one year was 0.5 ± 0.7. Patients with overlap syndrome had worse modified Medical Research Council dyspnoea scale scores and a lower percentage of rapid eye movement (REM) sleep than patients without. There were no other statistical differences in lung function or sleep study indices between the two patient groups.
CONCLUSION The majority of our patients had overlap syndrome and minimal exacerbations, and were not obese or sleepy. Significant differences between patients with and without overlap syndrome were seen in two aspects – the former was more dyspnoeic and had less REM sleep. Our findings suggest that standard clinical predictors cannot be used for patients with overlap syndrome, and therefore, a high index of suspicion is needed.

Keywords: chronic obstructive pulmonary disease, obstructive sleep apnoea, overlap syndrome
Singapore Med J 2014; 55(9): 488-492; http://dx.doi.org/10.11622/smedj.2014117

REFERENCES

1. Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med 1985; 6:651-61.
PMid:2935359
 
2. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182:325-31.
http://dx.doi.org/10.1164/rccm.200912-1869OC
 
3. Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:237-41.
http://dx.doi.org/10.1513/pats.200706-077MG
 
4. Sanders MH, Newman AB, Haggerty CL, et al; Sleep Heart Health Study. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003; 167:7-14.
http://dx.doi.org/10.1164/rccm.2203046
 
5. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005; 72:142-9.
http://dx.doi.org/10.1159/000084044
 
6. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55.
http://dx.doi.org/10.1164/rccm.200703-456SO
 
7. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103:30-6.
http://dx.doi.org/10.1378/chest.103.1.30
 
8. Ruehland WR, Rochford PD, O'Donoghue FJ, et al. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009; 32:150-7.
PMid:19238801 PMCid:PMC2635578
 
9. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15:173-84.
PMid:11032543
 
10. Natarajan R. Review of periodic limb movement and restless leg syndrome. J Postgrad Med 2010; 56:157-62.
http://dx.doi.org/10.4103/0022-3859.65284
 
11. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-12.
http://dx.doi.org/10.1056/NEJMoa021322
 
12. Rizzi M, Palma P, Andreoli A, et al. Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep Breath 1997; 2:68?72.
PMid:19404699
 
13. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370:741-50.
http://dx.doi.org/10.1016/S0140-6736(07)61377-4
 
14. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-5.
http://dx.doi.org/10.1056/NEJM199304293281704
 
15. Guilleminault C, Cummiskey J, Motta J. Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 1980; 122:397-406.
PMid:7416615
 
16. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151:82-6.
http://dx.doi.org/10.1164/ajrccm.151.1.7812577
 
17. Bradley TD, Rutherford A, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985; 131:835-9.
PMid:4003933
 
18. Bradley TD, Rutherford A, Lue F, et al. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 1986; 134:920-4.
PMid:3777688
 
19. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-39.
http://dx.doi.org/10.1164/rccm.2109080
 
20. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154:2219-24.
http://dx.doi.org/10.1001/archinte.1994.00420190121014
 
21. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.
http://dx.doi.org/10.1016/S0140-6736(03)15268-3
 
22. Agustí AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367-70.
http://dx.doi.org/10.1513/pats.200504-026SR
 
23. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003; 32:869-94.
http://dx.doi.org/10.1016/S0889-8529(03)00069-0
 
24. Li KK, Powell NB, Kushida C, et al. A comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope 1999; 109:1937-40.
http://dx.doi.org/10.1097/00005537-199912000-00007
 
25. Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med 2006; 100:658-65.
http://dx.doi.org/10.1016/j.rmed.2005.08.003
 
26. Casanova C, Cote CG, Marin JM, et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007; 29:535-40.
http://dx.doi.org/10.1183/09031936.00071506
 
27. Alameri H, Al-Kabab Y, BaHammam A. Submaximal exercise in patients with severe obstructive sleep apnea. Sleep Breath 2010; 14:145-51.
http://dx.doi.org/10.1007/s11325-009-0300-4
 
28. Cote CG, Casanova C, Marín JM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 2008; 31:571-8.
http://dx.doi.org/10.1183/09031936.00104507
 
29. Celli BR, Cote C, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-12.
http://dx.doi.org/10.1056/NEJMoa021322
 
30. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93:580-6.
http://dx.doi.org/10.1378/chest.93.3.580
 
31. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581-6.
http://dx.doi.org/10.1136/thx.54.7.581
 
32. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128-38.
http://dx.doi.org/10.1056/NEJMoa0909883
 
33. Serafini FM, MacDowell Anderson W, Rosemurgy AS, Strait T, Murr MM. Clinical predictors of sleep apnea in patients undergoing bariatric surgery. Obes Surg 2001; 11:28-31.
http://dx.doi.org/10.1381/096089201321454079
 
34. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999; 159:502-7.
http://dx.doi.org/10.1164/ajrccm.159.2.9804051
 
35. Saaresrantaa T, Irjalac K, Aittokalliod T, Polo O. Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease. Respir Med 2005; 99: 856-63.
http://dx.doi.org/10.1016/j.rmed.2004.11.017
 
36. Harding SM. Sleep in patients with pulmonary disease. In: Pagel JF, Pandi-Perumal SR, eds. Primary Care Sleep Medicine: A Practical Guide. Totowa: Humana Press Inc, 2007: 171-89.
http://dx.doi.org/10.1007/978-1-59745-421-6_16
 
37. Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007; 132:325-37.
http://dx.doi.org/10.1378/chest.07-0040
 
38. Leitch AG, Clancy LJ, Leggett RJ, et al. Arterial blood gas tensions, hydrogen ion, and electroencephalogram during sleep in patients with chronic ventilatory failure. Thorax 1976; 31:730-5.
http://dx.doi.org/10.1136/thx.31.6.730
 
39. Arand DL, McGinty DJ, Littner MR. Respiratory patterns associated with hemoglobin desaturation during sleep in chronic obstructive pulmonary disease. Chest 1981; 80:183-90.
http://dx.doi.org/10.1378/chest.80.2.183
 
40. Fleetham J, West P, Mezon B, et al. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis 1982; 126:429-33.
PMid:7125332
 
41. Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 1982; 126:206-10.
PMid:7103244
 
42. Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 1986; 41:846-54.
http://dx.doi.org/10.1136/thx.41.11.846
 
43. Charokopos N, Leotsinidis M, Pouli A, et al. Periodic limb movement during sleep and chronic obstructive pulmonary disease. Sleep Breath 2008; 12:155-9.
http://dx.doi.org/10.1007/s11325-007-0151-9

Preliminary study of an exercise programme for reducing fatigue and improving sleep among long-term haemodialysis patients

Share this Article

Singapore Med J 2014; 55(9): 476-482; http://dx.doi.org/10.11622/smedj.2014119
Preliminary study of an exercise programme for reducing fatigue and improving sleep among long-term haemodialysis patients

Maniam R, Subramanian P, Singh SK, Lim SK, Chinna K, Rosli R
Correspondence: Dr Pathmawathi Subramanian, pathmawathi@um.edu.my

ABSTRACT
INTRODUCTION Fatigue and quality of sleep are the main factors that contribute to a poor quality of life among patients on long-term haemodialysis. Studies have also emphasised the importance of exercise for improving the wellbeing of dialysis patients. This study aimed to determine the effectiveness of a predialysis low-to-moderate-intensity exercise programme for reducing fatigue and improving sleep disorders among long-term haemodialysis patients.
METHODS In this quasi-experimental study, an exercise programme was conducted three times a week for 12 weeks before long-term haemodialysis patients underwent dialysis at two centres. The patients were categorised into either the exercise group (n = 28) or control group (n = 27). The latter was asked to maintain their current lifestyles. Assessments of fatigue and sleep disorder levels were performed for both groups using self-reported questionnaires at baseline and after intervention. The patients’ perception of the exercise programme was also determined using self-reported questionnaires.
RESULTS Paired sample t-test indicated improvements in fatigue level in the exercise group (mean fatigue score: post-treatment 40.5 ± 7.9 vs. pre-treatment 30.0 ± 10.9). Improvements in sleep disorders were also observed in the exercise group (mean score: post-treatment 7.6 ± 3.3 vs. pre-treatment 10.1 ± 3.8). However, sleep quality deteriorated in the control group (mean score: post-treatment 10.7 ± 2.9 vs. pre-treatment 9.3 ± 2.9).
CONCLUSION Simple low-to-moderate-intensity exercise is effective for improving fatigue, sleep disorders and the overall quality of life among haemodialysis patients.

Keywords: exercise, fatigue, haemodialysis, sleep disorder
Singapore Med J 2014; 55(9): 476-482; http://dx.doi.org/10.11622/smedj.2014119

REFERENCES

1. Bonner A, Wellard S, Caltabiano M. The impact of fatigue on daily activity in people with chronic kidney disease. J Clin Nurs. 2010; 19:3006-15.
http://dx.doi.org/10.1111/j.1365-2702.2010.03381.x
 
2. Li M, Li L, Fan X. Patients Having Hemodialysis: Physical Activity and Associated Factors. J Adv Nurs. 2010; 66:1338-45.
http://dx.doi.org/10.1111/j.1365-2648.2010.05283.x
 
3. McCann K, Boore JRP. Fatigue in person with renal failure who require maintenance hemodialysis. J Adv Nurs. 2000; 32:1132-42.
http://dx.doi.org/10.1046/j.1365-2648.2000.01584.x
 
4. O'Sullivan D, McCarthy G. An Exploration of relationship between fatigue and physical functioning in patients with end stage renal disease receiving hemodialysis. J Clin Nurs. 2007; 16:276-84.
http://dx.doi.org/10.1111/j.1365-2702.2007.01965.x
 
5. Cupisiti A, Capitanini A, Betti G, D'Alessandro C, Barsotti G. Assessment of Habitual Physical Activity and Energy Expenditure in Dialysis Patients and Relationships to Nutritional Parameters. Clin Nephro. 2011; 75:3218?225.
 
6. Wong HS, Ong LM. Death And Survival On Dialysis: 18th Report of The Malaysian Dialysis and Transplant Registry.: The Malaysian Dialysis and Transplant Registry 2010.
 
7. Painter P, Carlson L, Carey S, Paul SM, Myll J. Physical Functioning and Health-Related Qulaity of Life Changes with Exercise Training in Hemodialysis Patients. Am J Kidney Dis. 2000; 35:482-92.
http://dx.doi.org/10.1016/S0272-6386(00)70202-2
 
8. Stack AG, Murthy B. Exercise and Limitations in Physical Activity Levels among New Dialysis Patients in the United States: An Epidemiologic Study. Am J Epid. 2008; 18:880-8.
 
9. Stamatakis E, Hamer M. Sedentary Behavior: Redefining its Meaning and Links to Chronic Diseases. Brit J Hosp Med. 2011; 72:192-5.
http://dx.doi.org/10.12968/hmed.2011.72.4.192
 
10. Chang Y, Cheng S-Y, Lin M, Gau F-Y, C. Chao Y-F. The effectiveness of intradialytic leg ergometry exercise for improving sedentary life style and fatigue among patients with chronic kidney disease: A randomized clinical trial. Int J Nurs Stud. 2010; 47:1383-8.
http://dx.doi.org/10.1016/j.ijnurstu.2010.05.002
 
11. Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications and interpretation. Health Qual Life Outcomes. 2003; 1:1-7.
http://dx.doi.org/10.1186/1477-7525-1-79
 
12. Borg GA. Psychophysical bases of percieved exertion. Med sci sports exerc. 1982; 14:377-81.
http://dx.doi.org/10.1249/00005768-198205000-00012
 
13. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in general population. Am Ca Society. 2002; 94:528-38.
 
14. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psyc Res. 1989; 28:193-213.
http://dx.doi.org/10.1016/0165-1781(89)90047-4
 
15. Edmunds J, Ntoumanis N, Duda JL. A Test of Self-Determination Theory in the Exercise Domain. J Applied Soc Psy. 2006; 36:2240-65.
http://dx.doi.org/10.1111/j.0021-9029.2006.00102.x
 
16. Lim YN, Ghazali A, Tan CC, Lee DG. Dialysis in Malaysia: 18th Report of The Malaysian Dilaysis and Transplant Registry 2010. Kuala Lumpur: Malaysia: Malaysian Society of Nephrology, 2011.
 
17. Karavatas SG, Tavakol K. Concurrent validity of borg's rating of perceived exertion in African-American young adults, employing heart rate as the standard. Internet J Allied Health Sciences Pract January 2005, Vol 3, No. 1.
 
18. Yusop NB, Yoke MC, Shariff ZM, Beng HC. Factors Associated with Quality of Life among Hemodialysis Patients in Malaysia. PLoS ONE. 2013; 8:e84152.
http://dx.doi.org/10.1371/journal.pone.0084152
 
19. Olson K. A New Way of Thinking about Fatigue: A Reconceptualization. Onco Nurs Forum. 2007; 34:93-9.
http://dx.doi.org/10.1188/07.ONF.93-99
 
20. Santhana L, Srijit D, Hasliza H, et al. Fatigue Experienced by Patients Receiving Maintenance Dialysis in Hemodialysis Units. Nurs Health Sciences. 2011:60-4.
 
21. Merlino G, Piani A, Dolso P, et al. Sleep Disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transp. 2005; 21:184?90.
http://dx.doi.org/10.1093/ndt/gfi144
 
22. Sklar AH, Riesenberg LA, Silber AK, Wagar A, Amir A. Postdialysis Fatigue. Am J Kidney Dis. 1996; 28:732-5.
http://dx.doi.org/10.1016/S0272-6386(96)90256-5
 
23. Yurtkuran M, Alp A, Yutkuran M, Dilek K. A modified yoga-based exercise program in hemodialysis patints: a randomized controlled study. Comp Therapies Med. 2007; 65:164-71.
http://dx.doi.org/10.1016/j.ctim.2006.06.008
 
24. Malagoni AM, Catizane L, Mandini S, et al. Acute and long term effects of an exercise program for dialysis patients prescribed in hospital and performed at home. J Nephrol. 2008; 21:871-8.
PMid:19034871
 
25. Reza A, Abbas E, Nader S, Sanavi S. Effects of Interdialytic Aerobic Training on Sleep Quality in Hemodialysis Patients. J Kidney Dis. 2011; 5:119-23.
 
26. van Vilsteren MCBA, Greef MHGd, Huisman RM. The effects of a low-to-moderate intensity pre-conditioning exercise program linked with exercise counseling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dialysis Transp. 2004; 20:141-6.
http://dx.doi.org/10.1093/ndt/gfh560
 
27. Cheema BSB, Singh MAF. Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Kidney Dis. 2005; 25:352- 64.
 
28. Ryan RM, Deci EL. Intrinsic and Extrinsic Motivations: Classic Definitions and New Directions. Contemp Edu Psycho. 2000; 25:54-67.
http://dx.doi.org/10.1006/ceps.1999.1020